why choose us

First received: October 19, 2024

Clinical Trial: A Combination of an Inhaled Budesonide and Ipratropium in Patients at Risk of Developing ARDS

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: ARDS

Study Type: INTERVENTIONAL


Official Title: A Combination of an Inhaled Budesonide and Ipratropium in Patients at Risk of Developing Acute Respiratory Distress Syndrome (ARDS): A Randomized Controlled Trial

Brief Summary: Acute respiratory distress syndrome (ARDS) is a severe lung condition with high morbidity and mortality, despite advances in medical care.It involves an intense inflammatory response in the lungs, leading to endothelial damage, increased capillary permeability, and fluid accumulation, causing hypoxemia and respiratory failure.ARDS can result from various pulmonary and non-pulmonary triggers.The 2012 Berlin criteria are widely used to diagnose ARDS, based on clinical signs, blood gas analysis, and chest imaging.The…

Read more